Product NewsLife Sciences

Webinar: Accelerating Product Development: from Transient Transfection to Stable Pools and Stable Clones

3 Dec 2014
Webinar: Accelerating Product Development: from Transient Transfection to Stable Pools and Stable Clones

This webinar highlights advantages of MaxCyte’s scalable flow electroporation technology for antibody and other protein production in CHO cells. Learn how the MaxCyte flow electroporation platform provides a universal means of fully scalable, highly efficient transient transfection for rapid high titer antibody production in CHO cells, often >1 gram/Liter with optimization.

Other videos from MaxCyte

Links